Physician profile
Stephanie Chery
NPI 1376007278
$1,138.41
in general payments reported to CMS, 2019-2025
15 companies · $560 in 2025
The $560 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $105 · 2022: $149 · 2023: $19.21 · 2024: $306 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $885.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $547.96 | 2024-2025 | Relistor |
| Boston Scientific Corporation | $141.10 | 2025 | Intracept |
| Biotissue Holdings INC. | $131.19 | 2022 | |
| Abbvie INC. | $49.53 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.30 | 2021 | |
| Valinor Pharma, LLC | $39.22 | 2025 | Movantik |
| Globus Medical, INC. | $28.18 | 2025 | Senza |
| Electronic Waveform Lab, INC. | $27.25 | 2024 | |
| Protega Pharmaceutials INC | $23.66 | 2025 | Roxybond |
| Terumo Medical Corporation | $20.79 | 2021 | |
| Kci USA, INC. | $20.31 | 2021 | |
| Merz Pharmaceuticals, LLC | $19.21 | 2023 | Xeomin |
| Bsn Medical INC | $17.36 | 2022 | |
| Novo Nordisk INC | $17.23 | 2021 | |
| Spr Therapeutics, INC | $9.12 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Chery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.